LPL activity assay.

PG Philip L.S.M. Gordts
RN Ryan Nock
NS Ni-Huiping Son
BR Bastian Ramms
IL Irene Lew
JG Jon C. Gonzales
BT Bryan E. Thacker
DB Debapriya Basu
RL Richard G. Lee
AM Adam E. Mullick
MG Mark J. Graham
IG Ira J. Goldberg
RC Rosanne M. Crooke
JW Joseph L. Witztum
JE Jeffrey D. Esko
request Request a Protocol
ask Ask a question
Favorite

LPL activity was determined as described previously (44, 45). Post-heparin plasma was obtained from fasted mice 5 minutes after retro-orbital injection of 5 units per mouse of heparin. To measure total lipase activity, plasma samples were incubated with 10% Intralipid/[3H]TG emulsion (Hospira) as a substrate and human serum as the source of ApoC-III (24). The contribution of hepatic lipase was determined by including 1 M NaCl in the assay, and the values were subtracted from the total lipase activity to estimate the activity attributed to LPL. Heparin-releasable LPL activity in heart, skeletal muscle, and white adipose tissue was measured using 50–80 mg of snap-frozen tissues. The tissue was minced in 0.6 ml PBS with 2 mg/ml BSA in the presence of 5 U/ml heparin. Minced tissues were incubated for 1 hour in a 37°C shaker and subsequently centrifuged at 1,000 g for 15 minutes. The supernatant was collected for LPL assay. A 100-μl aliquot of the buffer was used for the lipase assay in combination with 100 μl of a 10% Intralipid/[3H]triolein emulsion for 1 hour at 25°C. The LPL activity measurements were normalized for the initial tissue weights.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A